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M. Neutze. Green I.Bne Hospital, Auckland, New Zealand
113 30-day survivors of the Mustard repair undertaken between 1964 and
MLD(mm) Event Rate
Difference Treatment Control
Angiopeptin 0.01 22% 30% 003
CAVEAT I 0.11 28% 30% NS
BENESTENT 0.12 23% 33% <0.05
ACCORD 0.16 32% 32% NS
CAVEAT II 0.17 22% 33% 0.04
STRESS 0.20 20% 27% 008
The magnitude of the difference in MLD between the control and treat-
ment arms of each group is small in comparison with the difference in clin-
ical events detected, and there is no correlation between the magnitude of
MLD benefit and outcomes. Conclusion: While in some individual trials there
is concordance in angio-c1inical results, there is little evidence for this with
inter trial comparison. This suggests a treatment (medical or device) or trial
specific relationship rather than a direct linkage between MLD and clinical
outcomes.
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Long-term (28-Year) Follow-up of Mustard Repair for
Transposition of the Great Arteries with Intact
Ventricular Septum: Freedom from Right Ventricular
(Systemic) Heart Failure
Stent Non-stent p
Post-intervention
EEM area (mm2 ) 29.3 ± 118 204 ± 65 <0.0001
Lumen area (mm2 ) 8.5 ± 39 6.1 ± 2.4 <0.0001
Plaque area (mm 2) 20.9 ± 9.3 14.3 ± 5.7 <0.0001
Angiographic % diameter stenosis 9 ± 18 19± 14 0.0011
Follow-up
EEM area (mm2 ) 27.7 ± 9.5 187 ± 6.0 <0.0001
Lumen area (mm 2 1 6.5 ± 4.4 35 ± 3.0 <0.0001
Plaque area (mm 2) 22.0 ± 8.0 152 ± 5.5 <0.0001
Angiographic % diameter stenosis 36 ± 18 51 ± 26 0.005
Restenosis # (%) 8(23%) 77 (57%) 00017
Late lumen loss (mm2 ) 2.4 ± 2.6 2.6 ± 2.7 NS
Remodeling (mm2) 02 ± 13 1.7 ± 2.9 00061
Tissue growth (mm2) 2.2 ± 2.4 1.0 ± 2.3 0.0076
There is considerable controversy as to whether quantitative coronary angio-
plasty is a meaningful surrogate index for clinical outcomes after coronary
intervention. If a larger MLD reduces the incidence of restenosis, this in turn
should be associated with a decrease in the incidence of subsequent clinical
events. To study this phenomenon, we analyzed 6 major randomized trials
evaluating a variety of approaches to reduce restenosis following percuta-
neous revascularization. In 3 of the 6 trials compared to the control arm,
treatment was associated with significant decrease in the incidence of clin-
ical events secondary to restenosis Imyocardial infarction, death and need
for repeat revascularization) and an improvement in the MLD at the time of
follow-up catheterization. However, a similar or greater absolute MLD im-
provement did not yield clinical benefit in 2 trials, and 1 trial showed only
clinical benefit.
Long Term Follow-Up After Congenital Heart
Surgery
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Ernest N, Morial Convention Center, Room 103
Geometric remodeling is less (0.2 ± 1.3 vs 1.7 ± 2.9 mm2) and tissue
growth is greater (2.2 ± 2.4 vs 1.0 ± 2.3 mm2) in stented lesions than in
nonstented lesions. We Conclude: Stents reduce restenosis by achieving
a better primary (post-procedural) result and by eliminating geometric re-
modeling. The elimination of geometric remodeling offsets a stent-related
increase in plaque mass (tissue growth or neointimal hyperplasia) to prevent
restenosis.
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Dissociation Between Minimal Luminal Diameter and
Clinical Outcome at 6 Month Follow-up in Randomized
Trials of Percutaneous Revascularization
Robert L. Duerr. Eric J. Topol. Cleveland Clinic Foundation. Cleveland, OH
Factors Restenosis UN MR
No Yes
Lesions 256 64
Age 58 ± g 62 ± 9 0041 0.0001
Reference Vessel (mm) 3.35 ± 052 3.00 ± 0.52 0.0001 0.0001
Baseline MLD (mm) 0.97 ± 0.53 0.79 ± 044 0.019 ns
Final Stent MLD (mm) 3.46 ± 055 3.09 ± 0.52 0.0001 ns
Final % OS -8± 14 -5 ± 18 020 ns
Lesion Length (mml 8.8 ± 5.8 13 ± 7.8 00001 0.0001
Stent Number 1.4 ± 0.8 1.8 ± 13 00026 ns
Endovascular Stents Reduce Restenosis by
Eliminating Geometric Arterial Remodeling: A Serial
Intravascular Ultrasound Study
Gary S. Mintz, Augusto D. Pichard, Kenneth M. Kent, Lowell F. Satler, Jeffrey
J. Popma, S. Chiu Wong, Jack A. Painter, Debra DeForty, Martin B. Leon.
Washington Hospital Center. Washington, DC
MLD; Minimim lumen diameter, OS: Diameter stenosis
Conclusions. (1) In this cohort that had stent expansion optimized by IVUS
guidance, advanced age, small vessels and long lesion length were the
strongest independent predictors of restenosis. (2) These results confirm
previously reported analysis of angiographic data that small vessel diameter
is a strong predictor of restenosis. 13) Long lesion length rather than number
of stents is a stronger independent predictor of restenosis.
Intravascular ultrasound (IVUS) has been used to guide stent implantation
procedures and to optimize stent expansion. The long term effect that the im-
proved stent expansion achieved with IVUS guidance has on restenosis has
not been evaluated. Successful IVUS guided Palmaz Schatz coronary stent
implantation was performed in 429 consecutive lesions lies) in 359 patients
(pts).ln this cohort, based on IVUS evaluation, 70% of the stents required fur-
ther stent dilation despite an angiographic good result. Angiographic follow
up was obtained in 310 lesions (72%). Restenosis (by 50% diameter stenosis
criteria) occurred in 64 lesions (21 %). To determine the angiographic, clinical
and procedural factors associated with restenosis, univariate analysis (UN)
and stepwise logistical regression (MR) was performed on the 310 lesions
with angiographic follow up. The results between the restenosis (Yes) and
no restenosis (No) groups are summarized in the table below:
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Factors Associated with Late Angiographic Outcome
After Intravascular Ultrasound Guided Palmaz-Schatz
Coronary Stent Implantation: A Multivariate Analysis
Patrick Hall, Shigeru Nakamura, Luigi Maiello, Simonetta Blenglno,
Giovanni Martini, Leo Finci, Antonio Colombo. Columbus Hospital, Milan. Italy
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Previous studies have shown that (1) stents reduce restenosis, 12) stents
do not recoil, and (3) geometric remodeling may be an important contribut-
ing factor in restenosis. Therefore, to understand the mechanisms by which
stents reduce restenosis, we analyzed serial (post-intervention and follow-up
@ 5.0 ± 2.9 months) intravascular ultrasound and quantitative angiographic
studies in 33 stented lesions and compared the results to 135 nonstented le-
sions treated with various devices (30 PTCA, 57 directional and 26 rotational
atherectomy, and 22 excimer laser angioplasty). Post-intervention and follow-
up external elastic membrane (EEM), stent, and lumen areas were used to
calculate (1) plaque area, (2) late lumen loss (t. lumen area), (3) geometric
remodeling (I'. EEM area or I'. stent area in stented lesions and t.EEM area
in nonstented lesions), and (4) tissue growth t. (stent-lumen) area in stented
lesions and t. plaque area in nonstented lesions.
lesions that developed restenosis, versus 1.88 in the group that did not Ip
= 0.02). Similarly, diameter stenosis after BA was 43.4% versus 35.3%, re-
spectively (p < 0.0001), confirming previous studies.
As determined by 3 to 5 independent ICUS observers in each case, 86%
of lesions were ruptured (radial tear), with a restenosis rate of 32%, versus
18% in the non-ruptured lesions (p = 0.35). Dissection (circumferential tear)
was diagnosed in 64%, with a restenosis rate of 32%, versus 28% in the non-
dissected lesions (p = 0.65). Plaque type (soft 140%, restenosis 24%), hard
(10%, restenosis 27%) or calcific (50%, restenosis 33%), and eccentricity
(65%, restenosis 29%) did not predict the risk of restenosis. Two observers
independently measured lumen area, plaque area (media area minus lumen
area) and percent obstruction (plaque area/media area) on ICUS, and the two
values were averaged for analysis. There were no significant differences in
these parameters between groups with and without subsequent restenosis
Ip = 0.53, 0.44 and 0.16, respectively).
Conclusions: Qualitative and quantitative parameters on ICUS after suc-
cessful balloon angioplasty do not seem to predict the risk of angiographic
restenosis at 6 months.
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From 1973 through January 1, 1994, 860 Fontan procedures had been per-
formed at the Mayo Clinic with 39 (4.5%) having been done on patients with
PA and IVS. Age at surgery ranged from 1-10/12 to 21 years (median = 6).
Thirty-eight of the 39 patients had had a total of 71 prior palliative cardiovas-
cular procedures. Tricuspid valve (TV) and right ventricular (RV) size ranged
from "minuscule" to a maximum of 55% of expected. Only four patients had
significant right ventricular to coronary artery fistulae and only one of these
was "right ventricular coronary dependent".
There were three operative deaths (7.7%) and have been two sudden un-
expected late deaths (2-V, and 8 years post Fontan). One patient had a suc-
cessful cardiac transplant seven years post Fontan. Present ages of survivors
ranged from 3 to 29 years (median ~ 11.5 years) with a median post Fontan
follow-up of 5.3 years. At recent follow-up, 33 of 34 survivors were in good
or excellent condition and one was fair.
Conclusion: We feel patients with PA and IVS are not candidates for a
conventional two ventricle repair unless the TV and RV are at least 70% of
expected size. In patients with dimensions between 50% and 70%, a two
ventricle repair combined with a bidirectional cavopulmonary anastomosis
may be feasible. In patients with TV and RV size less than 50% of expected,
the Fontan procedure provides "definitive palliation" and early and late results
of this approach are encouraging.
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[702-41 The Fontan Procedure for Pulmonary Atresia and
Intact Ventricular Septum (PA and IVS): Operative
and Late Results
Frank Cetta, Robert H. Feldt, Patrick W. O'Leary, Douglas D. Mair, Carole
A. Warnes, Kenneth P. Offord, Francisco J. Puga, Hartzell V. Schaff, Gordon
K. Danielson. Mayo Clinic, Rochester, Minnesota
The modified Fontan operation (MF) is the preferred palliative procedure for
heterotaxy pts (HP) with complex cyanotic heart disease. Early mortality (EM)
after MF has been reported to be greater for HP In our recent experience
(1987 - 92) EM after MF has improved dramatically. In order to determine if
these improved results applied to HP.we reviewed all HPwho had a MF atour
institution between 1973 - 92 (n = 111). From 1973-92, 111/839 (13%) pts
having a MF were HP 154 (6.5%1 polysplenia, 57 (6.8%) asplenia]. HP were
significantly older than non-HP at the time of MF (median age = 11 yrs vs 9
yrs; p < 0.05). We compared EM after MF for HP in two time periods: early
11973-86 In = 49)] and recent [1987-92 (n = 62)]. EM decreased significantly
in the recent group [9/62 (14.5%1] compared to the early group 121/49 (43%);
p < 0.001]. In our early experience, asplenia pts had increased EM compared
to polysplenia pts (65% vs 23%) but, recent experience shows that EM is
similar for these two subsets of HP [asplenia: 5/34 (15%1 vs polysplenia: 4/28
(14%)]. Many factors, including use of an intra-atrial tunnel, have contributed
to these improved results.
Despite the recent reduction in EM for HP. this group remains at higher
risk after MF than pts with tricuspid atresia (EM ~ 4%) or double inlet left
ventricle (EM = 4%). This is most likely due to increased frequency of com-
plicating features present in HP compared to non-HP For example, atrioven-
tricular valve (AW) repair/replacement, a recognized risk factor for EM, was
more frequent in HP than non-HP [28/62 (45%) vs 40/277 (14%); P < O.OOlJ.
In HP who did not have AW procedures EM was 9% (3/34) compared to
21 % (6/28) in HP who had AVV procedures. The 9% EM rate observed in HP
without AW procedures is not significantly different from the 4% EM rate
observed in non-HP (p = 0.2). Conclusion: Survival after MF for HP has im-
proved dramatically. Although HP still experience a greater overall operative
risk, some subgroups had EM rates which were not significantly different
from non-HP
tecto my lOR 1.7), peri-operative bradyarrhythmias (OR 1.7) and occurrence
of atrial flutter (AFL) during follow-up. Instantaneous hazard of LSR showed
a gradual decline after MUST with a second late peak. AFL was noted in 15%
of survivors; freedom from AFL was 92% at 5 yr, 89% at 10 yr, 82% at 15 yr
and 71 % at 20 yr. Patients who were on digoxin vs. no medication at the time
of their first AFL episode were less likely to have symptoms of presyncope
or syncope (7% vs. 33%, P = 0.06). Independent factors associated with late
AFL included: LSR (OR 2.6) and peri-operative arrhythmias including AFL (OR
3.1). bradyarrhythmias (OR 2.5) and permanent heart block (OR 12.2). Instan-
taneous hazard of AFL showed a gradual incline with a late peak. Conclusion:
Late peaks in the risk of death, LSR and AFL necessitate ongoing fOllOW-Up
in this population.
Douglas D. Mair, Gordon K. Danielson, Francisco J. Puga. Mayo Clinic, Rocheste"
Minnesota
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1702-51 Improved Survival After Fontan Operation for 62
Heterotaxy Patients
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Although RV dysfunction is frequently observed, actuarial freedom from
RVF is 97% at 18 years.
Conclusion: Progressive right ventricular failure is rare following the Mus-
tard operation for simple transposition with intact septum.
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1702-21 Right Ventricular Function in Adolescents and Young
Adults After Previous Mustard Operation
Mark Gelatt, Robert M. Hamilton, Brian W. McCrindle, Michael S. Connelly,
Andrew M. Davis, Louise Harris, Robert M. Gow, William G. Williams, George
A. Trusler, Robert M. Freedom. UniversitvofToronto, Toronto, Canada
To determine factors associated with survival and arrhythmias, we reviewed
534 (359 males) consecutive patients after Mustard operation (MUST) for
transposition of the great arteries (TGA) from 1963 to 1993. TGA was iso-
lated for 354 pts, associated with VSD in 73, pulmonary obstruction (PS) in
50, VSD with PS in 46 and complex anomalies in 11. Median age at MUST
was 16 months (range, 21 days to 19 yrsl. There were 52 hospital deaths
(9.7%). Late death occurred in 76 of 482 operative survivors (15.8%) with up
to 31 years follow-up (mean 12.6 ± 6.8 yrs). Late survival was 89% at 5 yr,
88% at 10 yr, 82% at 15 yr and 76% at 20 yr. Mode of late death included:
Sudden, 39%; myocardial failure, 27%; pulmonary vascular disease, 10%;
reoperation, 7%; pulmonary venous obstruction, 4%; non-cardiac, 4%; and
other, 9%. Cox's proportional hazard modelling was used to assess indepen-
dent factors associated with late death. Significant factors included: earlier
date of operation (Odds Ratio, OR, 0.75 per 5 yrs). VSD closure at MUST (OR
2.5), and peri-operative atrial tachyarrhythmias at MUST (OR 1.9). Instanta-
neous risk (hazard) of late death declined, with a late peak and decline. Loss
of sinus rhythmn (LSR) was noted in 29% of survivors: freedom from LSR
was 82% at 5 yr, 67% at 10 yr, 60% at 15 yr and 52% at 20 yr. Significant inde-
pendent factors associated with LSR included: pre-MUST surgical atrial sep-
1982 were followed by serial cardiological review and a recent symptom
questionnaire. Follow-up of late survivors was 10--28 years; 40 survive >20
years postoperatively. Right ventricular failure (RVF) was diagnosed if there
were clinical signs and/or supportive radiological, echocardiographic or ra-
dionuclide evidence of progressive right heart dysfunction. Non-progressive
RV dilatation was labelled RV dysfunction. Resu/ts: Actuarial survival was
93%, 90%, 84%, 80% and 80% at 5, 10, 15, 20 and 24 years respectively.
Causes of the 19 deaths were: baffle obstruction 4; sudden, presumed ar-
rhythmia 6; pulmonary vascular disease 2; miscellaneous 5; and RVF 2.
The long term status of right ventricular function after intra-atrial baffle repair
(Mustardl for transposition of the great arteries (TGA) was evaluated. Right
ventricular ejection fraction (RVEF) and tricuspid regurgitation (TRI were es-
timated by radionuclide angiocardiography in 58 pts who were at least 10
yrs post-Mustard (mean age, 14 ± 3 yrs). Mean RVEF of 0.53 ± 0.10 did not
differ from our normal. However, in 9 pts the most recent RVEF was <0.42,
placing them >2SD below normal. Serial RVEF in 32 pts fell from a group
mean of 0.54 ± 0.11 to 0.51 ± 0.11 (p < 0.1) over 9 ± 2 yrs In 10 of these
32, RVEF either dropped to <0.42 or decreased >0.10 between studies. Sig-
nificant TR was present in 27/52, and increased in 8 studied serially. This
data demonstrates 1) though group RVEF in adolescent and young adult pts
with previous Mustard is normal, almost 17% of pts have depressed func-
tion; 2) RVEF often worsens when studied serially in older pts; and 3) TR is
significant in over half the previously operated pts. Though most of these
post-operative TGA pts are free of clinical symptoms through adolescence,
they are at significant risk for deterioration of function.
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1702-31 Factors Associated With Arrhythmias After Mustard
Operation-30 Year Experience with 534 Patients
